Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Wednesday 25 September, 2019

AIM

Readmission - Amryt Pharma Plc

RNS Number : 4944N
AIM
25 September 2019
 

NOTICE

 

25/09/2019 - 8.00am

 

NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM - XLON

 

Following a Reverse Takeover the following securities have been cancelled from trading on AIM with effect from the time and date of this notice.

 

AMRYT PHARMA PLC

213800YNUJEOJ84L4T95

ORDINARY SHARES OF 6P EACH, FULLY PAID

(BKB1MS3)(GB00BKB1MS30)

AMRT PHAR/PAR VTG FPD 0.06

 

If you have any queries or require further information, please contact the company's nominated adviser.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
AMOSEEFELFUSEEU

a d v e r t i s e m e n t